Politis, M., Oertel, W. H., Wu, K., Quinn, N. P., Pogarell, O.
, Brooks, D. J., Bjorklund, A., Lindvall, O. & Piccini, P. (2011).
Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio.
Movement Disorders,
26(11), 1997-2003.
https://doi.org/10.1002/mds.23743
Ahmed, I., Bose, S. K.
, Pavese, N., Ramlackhansingh, A., Turkheimer, F., Hotton, G., Hammers, A.
& Brooks, D. J. (2011).
Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias.
Brain,
134(Pt 4), 979-86.
https://doi.org/10.1093/brain/awr028
Brooks, D. J., Beaney, R. P., Lammertsma, A. A., Herold, S., Turton, D. R., Luthra, S. K., Frackowiak, R. S., Thomas, D. G., Marshall, J. & Jones, T. (1986).
Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
Journal of Cerebral Blood Flow and Metabolism,
6(2), 230-239.
https://doi.org/10.1038/jcbfm.1986.36
DellaValle, B., Brix, G. S., Brock, B.
, Jensen, M. G., Landau, A. M., Møller, A.
, Rungby, J. & Larsen, A. (2016).
Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats.
Frontiers in Pharmacology,
7(NOV), 433. Article 433.
https://doi.org/10.3389/fphar.2016.00433
Tomasi, G., Bertoldo, A., Cobelli, C.
, Pavese, N., Tai, Y. F., Hammers, A. & Turkheimer, F. E. (2011).
Global-two-stage filtering of clinical PET parametric maps: Application to [11C]-(R)-PK11195.
NeuroImage,
55(3), 942-953.
https://doi.org/10.1016/j.neuroimage.2010.12.056
Love, S., Plaha, P., Patel, N. K., Hotton, G. R.
, Brooks, D. J. & Gill, S. S. (2005).
Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain.
Nature Medicine,
11(7), 703-704.
https://doi.org/10.1038/nm0705-703
Ros, R., Garre, P. G., Hirano, M., Tai, Y. F., Ampuero, I., Vidal, L., Rojo, A., Fontan, A., Vazquez, A., Fanjul, S., Hernandez, J., Cantarero, S., Hoenicka, J., Jones, A., Ahsan, R. L.
, Pavese, N., Piccini, P.
, Brooks, D. J., Perez-Tur, J. ... De Yébenes, J. G. (2005).
Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1.
Annals of Neurology,
57(5), 634-641.
https://doi.org/10.1002/ana.20449
Nombela, C., Rowe, J. B., Winder-Rhodes, S. E., Hampshire, A., Owen, A. M., Breen, D. P., Duncan, G. W., Khoo, T. K., Yarnall, A. J., Firbank, M. J., Chinnery, P. F., Robbins, T. W., O'Brien, J. T.
, Brooks, D. J., Burn, D. J., Barker, R. A. & ICICLE-PD Study Group (2014).
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.
Brain,
137(Pt 10), 2743-58.
https://doi.org/10.1093/brain/awu201
Cai, X. L., Xie, D. J., Madsen, K. H., Wang, Y. M., Bögemann, S. A., Cheung, E. F. C.
, Møller, A. & Chan, R. C. K. (2020).
Generalizability of machine learning for classification of schizophrenia based on resting-state functional MRI data.
Human Brain Mapping,
41(1), 172-184.
https://doi.org/10.1002/hbm.24797
Martinez-Martin, P., Falup Pecurariu, C., Odin, P., van Hilten, J. J., Antonini, A., Rojo-Abuin, J. M., Borges, V., Trenkwalder, C., Aarsland, D.
, Brooks, D. J. & Ray Chaudhuri, K. (2012).
Gender-related differences in the burden of non-motor symptoms in Parkinson's disease.
Nevrologicheskii Zhurnal,
259(8), 1639-47.
https://doi.org/10.1007/s00415-011-6392-3
Opacka-Juffry, J., Ashworth, S., Hume, S. P., Martin, D.
, Brooks, D. J. & Blunt, S. B. (1995).
GDNF protects against 6-ohda nigrostriatal lesion: In vivo study with microdialysis and PET.
NeuroReport,
7(1), 348-352.
https://doi.org/10.1097/00001756-199512290-00083
Cury, R. G.
, Pavese, N., Aziz, T. Z., Krauss, J. K., Moro, E. & the Neuromodulation of Gait Study Group from Movement Disorders Society (2022).
Gaps and roadmap of novel neuromodulation targets for treatment of gait in Parkinson’s disease.
npj Parkinson's Disease ,
8(1), Article 8.
https://doi.org/10.1038/s41531-021-00276-6
Thomsen, K. R., Peterson, E., Doudet, D.
, Gjedde, A., Møller, A. & Linnet, J. (2007).
Gambling as Self-medication? - Preliminary results on Dopamine and Depression in Pathological Gambling. In
Sixth Annual OAK Meeting for Danish Laboratories
Sigurdsson, H. P., Yarnall, A. J., Galna, B., Lord, S., Alcock, L., Lawson, R. A., Colloby, S. J., Firbank, M. J., Taylor, J.-P.
, Pavese, N., Brooks, D. J., O'Brien, J. T., Burn, D. J. & Rochester, L. (2022).
Gait-Related Metabolic Covariance Networks at Rest in Parkinson's Disease.
Movement Disorders,
37(6), 1222-1234.
https://doi.org/10.1002/mds.28977
Boecker, H., Weindl, A.
, Brooks, D. J., Ceballos-Baumann, A. O., Liedtke, C., Miederer, M., Sprenger, T., Wagner, K. J. & Miederer, I. (2010).
GABAergic dysfunction in essential tremor: An11C-flumazenil PET study.
Journal of Nuclear Medicine,
51(7), 1030-1035.
https://doi.org/10.2967/jnumed.109.074120
Lingford-Hughes, A. R., Wilson, S. J., Cunningham, V. J., Feeney, A., Stevenson, B.
, Brooks, D. J. & Nutt, D. J. (2005).
GABA-benzodiazepine receptor function in alcohol dependence: A combined 11C-flumazenil PET and pharmacodynamic study.
Psychopharmacology,
180(4), 595-606.
https://doi.org/10.1007/s00213-005-2271-x
Rakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P. K., Ashburner, J., Dagher, A., Jenkins, I. H., Friston, K. J.
& Brooks, D. J. (1999).
Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease. A 3D [18F]dopa-PET study.
Brain,
122(9), 1637-1650.
https://doi.org/10.1093/brain/122.9.1637
Abrahams, S., Goldstein, L. H., Kew, J. J. M.
, Brooks, D. J., Lloyd, C. M., Frith, C. D. & Leigh, P. N. (1996).
Frontal lobe dysfunction in amyotrophic lateral sclerosis: A PET study.
Brain,
119(6), 2105-2120.
https://doi.org/10.1093/brain/119.6.2105
Fan, Z., Calsolaro, V., Atkinson, R. A., Femminella, G. D., Waldman, A., Buckley, C. J., Trigg, W.
, Brooks, D. J., Hinz, R. & Edison, P. (2016).
Flutriciclamide (F-18-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein.
Journal of Nuclear Medicine,
57(11), 1753-1759.
https://doi.org/10.2967/jnumed.115.169078
Lucetti, C., Nuti, A.
, Pavese, N., Gambaccini, G., Rossi, G. & Bonuccelli, U. (1998).
Flunarizine in migraine prophylaxis: Predictive factors for a positive response.
Cephalalgia,
18(6), 349-352.
https://doi.org/10.1046/j.1468-2982.1998.1806349.x
van Hartevelt, T. J., Cabral, J.
, Møller, A., Fitzgerald, J. J., Green, A. L., Aziz, T. Z., Deco, G.
& Kringelbach, M. L. (2014).
First evidence of neural mechanisms of Hebbian changes in white matter tracts induced by long-term deep brain stimulation. Poster session presented at Society for Neuroscience 2014, Washington DC, United States.
Fuxe, K., Chadi, G., Agnati, L. F., Tinner, B., Rosén ., Janson, A. M.
, Møller, A., Cintra, A., Cao, Y., Goldstein, M., Lindahl, U., David, G., Ögren, O., Toffano, G., Baird, A. & Pettersson, R. F. (1994).
Fibroblast growth factor-2, ganglioside GM1 and the trophic regulation of the basal ganglia. Focus on the nigrostriatal dopamine neurons. Pergamon Press,
62, 1-42.
Pavese, N., Metta, V., Bose, S. K., Chaudhuri, K. R.
& Brooks, D. J. (2010).
Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction.
Brain,
133(11), 3434-3443.
https://doi.org/10.1093/brain/awq268
Piccini, P., De Yebenez, J., Lees, A. J., Ceravolo, R., Turjanski, N., Pramstaller, P.
& Brooks, D. J. (2001).
Familial progressive supranuclear palsy: Detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
Archives of Neurology,
58(11), 1846-1851.
https://doi.org/10.1001/archneur.58.11.1846
Piccini, P.
, Pavese, N., Hagell, P., Reimer, J., Björklund, A., Oertel, W. H., Quinn, N. P.
, Brooks, D. J. & Lindvall, O. (2005).
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.
Brain,
128(12), 2977-2986.
https://doi.org/10.1093/brain/awh649
Cristiano Real Gregório, C., Henrique Binda, K. & Landau, A. (2021).
Factors Affecting Neurological Aging: Genetics, Neurology, Behavior, and Diet: Treadmill exercise and neuroinflammation: Links with aging. In
Factors Affecting Neurological Aging: Genetics, Neurology, Behavior, and Diet: Treadmill exercise and neuroinflammation: Links with aging (pp. 385-401). Academic Press.
McGinnity, C. J., Hammers, A., Barros, D. A. R., Gousias, I. S., Luthra, S. K., Jones, M. P. A., Trigg, W.
, Brooks, D. J., Koepp, M. J. & Duncan, J. S. (2011).
[F-18]GE-179 PET DEMONSTRATES INCREASED NMDA RECEPTOR AVAILABILITY IN PATIENTS WITH REFRACTORY EPILEPSY AND FREQUENT INTERICTAL EPILEPTIFORM DISCHARGES (IEDS).
Epilepsia,
52, 19-19.
Stokholm, M. G., Iranzo, A., Østergaard, K., Serradell, M.
, Otto, M., Svendsen, K. B., Garrido, A., Vilas, D.
, Parbo, P., Borghammer, P., Santamaria, J.
, Møller, A., Gaig, C.
, Brooks, D. J., Tolosa, E.
& Pavese, N. (2018).
Extrastriatal monoaminergic dysfunction and enhanced microglial activation in idiopathic rapid eye movement sleep behaviour disorder.
Neurobiology of Disease,
115, 9-16.
https://doi.org/10.1016/j.nbd.2018.02.017
Lloyd, C. M., Richardson, M. P.
, Brooks, D. J., Al-Chalabi, A. & Leigh, P. N. (2000).
Extramotor involvement in ALS: PET studies with the GABA(A) ligand [11C]flumazenil.
Brain,
123(11), 2289-2296.
https://doi.org/10.1093/brain/123.11.2289
Samuel, M., Williams, S. C. R., Leigh, P. N., Simmons, A., Chakraborti, S., Andrew, C. M., Fristen, K. J., Goldstein, L. H.
& Brooks, D. J. (1998).
Exploring the temporal nature of hemodynamic responses of cortical motor areas using functional MRI.
Neurology,
51(6), 1567-1575.
https://doi.org/10.1212/WNL.51.6.1567
Linnet, J., Josefsen, L. G.
, Mouridsen, K., Shaffer, H. J.
& Møller, A. (2010).
Experienced Poker Players Differ in Estimation Bias and Decision Bias from Inexperienced Poker Players. Journal of Gambling Issues, (24), 86-100.
Lou, H. O. C., Rosenstand, A.
, Brooks, D. J., Bender, D., Jakobsen, S., Blicher, J. U., Hansen, K. V.
& Møller, A. (2016).
Exogenous dopamine reduces GABA receptor availability in the human brain.
Brain and Behavior,
6(7), e00484. Article e00484.
https://doi.org/10.1002/brb3.484
Binda, K. H., Lillethorup, T. P., Real, C. C., Bærentzen, S. L., Nielsen, M. N., Orlowski, D., Brooks, D. J., Chacur, M.
& Landau, A. M. (2021).
Exercise protects synaptic density in a rat model of Parkinson's disease.
Experimental Neurology,
342, 113741. Article 113741.
https://doi.org/10.1016/j.expneurol.2021.113741
Husum, H., Aznar, S., Hoyer-Hansen, S., Larsen, M. H.
, Møller, A., Malthe, A. A. & Worthwein, G. (2006).
Exacerbated loss of cell survival, neuropeptide Y-immunoreactive (IR) cells, and serotonin-IP fiber lengths in the dorsal hippocampus of the aged flinders sensitive line "depressed" rat: Implications for the pathophysiology of depression? J Neurosci Res.,
84(6), 1292-1302.
Turner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E.
, Brooks, D. J., Leigh, P. N. & Banati, R. B. (2004).
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study.
Neurobiology of Disease,
15(3), 601-609.
https://doi.org/10.1016/j.nbd.2003.12.012
Politis, M., Piccini, P.
, Pavese, N., Koh, S. B.
& Brooks, D. J. (2008).
Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo 11C-raclopride PET study.
Experimental Neurology,
214(1), 112-116.
https://doi.org/10.1016/j.expneurol.2008.07.021
van Hartevelt, T. J.
, Cabral, J., Møller, A., FitzGerald, J. J., Green, A. L., Aziz, T. Z., Deco, G.
& Kringelbach, M. L. (2015).
Evidence from a rare case study for Hebbian-like changes in structural connectivity induced by long-term deep brain stimulation.
Frontiers in Behavioral Neuroscience,
9, 167.
https://doi.org/10.3389/fnbeh.2015.00167
Samuel, M., Ceballos-Baumann, A. O., Blin, J., Uema, T., Boecker, H., Passingham, R. E.
& Brooks, D. J. (1997).
Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study.
Brain,
120(6), 963-976.
https://doi.org/10.1093/brain/120.6.963
Taylor-Robinson, S. D., Weeks, R. A., Sargentoni, J., Marcus, C. D., Bryant, D., Harding, A. E.
& Brooks, D. J. (1994).
Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy [23].
Lancet,
343(8906), 1169-1170.
https://doi.org/10.1016/S0140-6736(94)90279-8
Grasby, P. M., Koepp, M. J., Gunn, R. N., Cunningham, V. J., Lawrence, A. D., Dagher, A., Jones, T.
, Brooks, D. J. & Bench, C. J. (1998).
Evidence for dopamine release during a videogame using [11C]Raclopride PET.
NeuroImage,
7(4 PART II).
Hu, M. T. M., Taylor-Robinson, S. D., Ray Chaudhuri, K., Bell, J. D., Morris, R. G., Clough, C.
, Brooks, D. J. & Turjanski, N. (1999).
Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: A proton MR spectroscopy study.
Journal of Neurology Neurosurgery and Psychiatry,
67(1), 20-26.
https://doi.org/10.1136/jnnp.67.1.20
Linnet, J.
, Rømer Thomsen, K., Møller, A. & Callesen, M. B. (2010).
Event frequency, excitement, and desire to gamble among pathological gamblers.
International Gambling Studies,
10(2), 177-188.
Johansen, J., Rosenblad, C., Andsberg, K.
, Møller, A., Lundberg, C., Björlund, A. & Johansen, TE. (2002).
Evaluation on Tet-on system to avoid transgene downregulation in ex vivo gene transfer to the CNS.
Gene Therapy,
9, 1291-1301.
Rabey, J. M., Bass, H., Bonuccelli, U.
, Brooks, D., Klotz, P., Korczyn, A. D., Kraus, P., Martinez-Martin, P., Morrish, P., Van Sauten, W. & Van Hilten, B. (1997).
Evaluation of the Short Parkinson's Evaluation Scale: A new friendly scale for the evaluation of Parkinson's disease in clinical drug trials.
Clinical Neuropharmacology,
20(4), 322-337.
https://doi.org/10.1097/00002826-199708000-00004
Landau, A. M., Olsen, A. K., Wegener, G., Videbech, P.
, Gjedde, A. & Doudet, D. (2007).
Evaluation of the role of monoamines in electroconvulsive therapy in an animal model of Parkinsons Disease - a project proposal. Abstract from Forskningens Dag, Århus, Denmark.
Landau, A. M., Nahimi, A.
, Olsen, A. K., Wegener, G., Videbech, P.
, Møller, A., Gjedde, A. & Doudet, D. (2008).
Evaluation of the role of monoamines in electroconvulsive therapy in an animal model of Parkinson´s Disease. Abstract from OAK Meeting, Odense, Denmark.
Landau, A. M., Nahimi, A.
, Olsen, A. K., Wegener, G., Videbech, P.
, Gjedde, A. & Doudet, D. (2008).
Evaluation of the role of monoamines in electroconvulsive therapy in an animal model of Parkinson´s Disease. Abstract from Proceedings from the 1st international ISBS Summer School on Behavioral Genetics and Neuroscience of Stress, St Petersburg, Russian Federation.
Sommerauer, M.
, Fedorova, T. D., Hansen, A. K., Knudsen, K., Otto, M., Jeppesen, J., Frederiksen, Y., Blicher, J. U., Geday, J.
, Nahimi, A., Damholdt, M. F., Brooks, D. J. & Borghammer, P. (2018).
Evaluation of the noradrenergic system in Parkinson's disease; an 11C-MeNER PET and neuromelanin MRI study.
Brain,
141(2), 496-504.
https://doi.org/10.1093/brain/awx348
Hume, S. P., Luthra, S. K., Brown, D. J., Opacka-Juffry, J., Osman, S., Ashworth, S., Myers, R., Brady, F., Carroll, F. I., Kuhar, M. J.
& Brooks, D. J. (1996).
Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter.
Nuclear Medicine and Biology,
23(3), 377-384.
https://doi.org/10.1016/0969-8051(96)00019-4
Venkataraman, A. V., Mansur, A., Huiban, M., Passchier, J., Rowe, J. B., Tsukada, H.
, Brooks, D., Gunn, R. N., Matthews, P. M., Rabiner, E. A. & MINDMAPS Consortium (2019).
Evaluation of mitochondrial and synaptic function in Alzheimer's disease (AD): a [F-18]BCPP-EF, [C-11]SA4503 and [C-11]UCB-J PET study.
Journal of Cerebral Blood Flow and Metabolism,
39(Suppl. 1), 121-122.
Sager, T. N., Topp, S., Torup, L., Egestad, B.
& Møller, A. (2001).
Evaluation of CA1 damage using single-voxel 1H-MRS and un-biased stereology: Can non-invasive measures of N-acetyl-asparate following global ischemia be used as a reliable measure of neuronal damage? Brain Research,
892, 166-175.
Hirani, E., Gillies, J., Karasawa, A., Shimada, J., Kase, H., Opacka-Juffry, J., Osman, S., Luthra, S. K., Hume, S. P.
& Brooks, D. J. (2001).
Evaluation of [4-O-methyl-11C]KW-6002 as a potential PET ligand for mapping central adenosine A2A receptors in rats.
Synapse,
42(3), 164-176.
https://doi.org/10.1002/syn.1110
Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B. R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K. ... Edison, P. (2019).
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Trials,
20(1), Article 191.
https://doi.org/10.1186/s13063-019-3259-x
Doudet, D.
, Wegener, G., Jakobsen, S., Alstrup, A. K. O., Mørk, A.
, Sørensen, J. C. H. & Landau, A. M. (2012).
Evaluating NA release with C-11 yohimbine: combined in vivo PET-microdialysis studies. Abstract from The 9th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, Baltimore, United States.
Lang, A. E., Gill, S., Patel, N. K., Lozano, A., Nutt, J. G., Penn, R.
, Brooks, D. J., Hotton, G., Moro, E., Heywood, P., Brodsky, M. A., Burchiel, K., Kelly, P., Dalvi, A., Scott, B., Stacy, M., Turner, D., Wooten, V. G. F., Elias, W. J. ... Traub, M. (2006).
Erratum: Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease (Annals of Neurology (2006) 59 (459-466)).
Annals of Neurology,
60(6).
https://doi.org/10.1002/ana.21061
Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M.
, Brooks, D. J., Svendsen, C. N. & Heywood, P. (2006).
Erratum: ADDENDUM: Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (Nature Medicine (2003) 9 (589-595)).
Nature Medicine,
12(4).
https://doi.org/10.1038/nm0406-479
Boecker, H., Dagher, A., Ceballos-Baumann, A. O., Passingham, R. E., Samuel, M., Friston, K. J., Poline, J. B., Dettmers, C., Conrad, B.
& Brooks, D. J. (1998).
Erratum: Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: Investigations with H2 15O PET (Journal of Neurophysiology (February 1998) 79 (1070-1080)).
Journal of Neurophysiology,
79(4).
Aamand, R., Skewes, J., Møller, A., Fago, A. & Roepstorff, A. (2011).
Enhancing effects of acetazolamide on neuronal activity correlate with enhanced visual processing ability in humans.
Neuropharmacology,
61(5-6), 900-908.
https://doi.org/10.1016/j.neuropharm.2011.06.010
Landau, A. M., Alstrup, A. K. O., Audrain, H., Jakobsen, S., Simonsen, M., Møller, A., Videbech, P. B.
, Wegener, G., Gjedde, A. & Doudet, D. J. (2018).
Elevated dopamine D1 receptor availability in striatum of Göttingen minipigs after electroconvulsive therapy.
Journal of Cerebral Blood Flow and Metabolism,
38(5), 881-887.
https://doi.org/10.1177/0271678X17705260
Alstrup, A. K. O., Landau, A. M., Møller, A., Simonsen, M.
, Jakobsen, S., Audrain, H., Videbech, P.
, Wegener, G., Gjedde, A. & Doudet, D. (2011).
Elektrochok påvirker hjernens dopamin- og noradrenalin receptor-binding hos Göttingen minigrise. Poster session presented at Psykiatriens Forskningsdag.
Landau, A. M., Alstrup, A. K. O., Møller, A., Jakobsen, S., Wegener, G., Videbech, P., Vang, K.
, Gjedde, A. & Doudet, D. (2009).
Electroconvulsive therapy induces alterations in monoaminergic receptor binding in the striatum and frontal cortex of healthy minipigs. Abstract from OAK Meeting, Århus, Denmark.
Landau, A. M., Alstrup, A. K. O., Møller, A., Simonsen, M.
, Jakobsen, S., Videbech, P.
, Wegener, G., Gjedde, A. & Doudet, D. (2010).
Electroconvulsive therapy alters monoamine receptor binding in the brain of Göttingen minipigs: mechanistic clues into antidepressant action. Abstract from Society for Neuroscience.
Landau, A. M., Mallar, C., Clark, C. M., Zis, A. P. & Doudet, D. J. (2011).
Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates.
Neuropsychopharmacology,
36(2), 511-8.
https://doi.org/10.1038/npp.2010.182
Landau, A. M., Alstrup, A. K. O., Møller, A., Simonsen, M.
, Jakobsen, S., Videbech, P.
, Wegener, G., Gjedde, A. & Doudet, D. (2011).
Electroconvulsive therapy alters dopamine and noradrenaline receptor binding in the göttingen minipig brain. Abstract from World Molecular Imaging Congress (WMIC) , San Diego, United States.
Landau, A., Alstrup, A. K. O., Noer, O., Winterdahl, M., Audrain, H., Møller, A., Videbech, P.
, Wegener, G., Gjedde, A. & Doudet, D. J. (2019).
Electroconvulsive stimulation differentially affects [11C]MDL100,907 binding to cortical and subcortical 5HT2A receptors in porcine brain.
Journal of Psychopharmacology,
33(6), 714-721. Article 269881119836212.
https://doi.org/10.1177/0269881119836212
Lillethorup, T. P., Iversen, P., Fontain, J.
, Wegener, G., Doudet, D. J.
& Landau, A. M. (2015).
Electroconvulsive shocks decrease α2-adrenoceptor binding in the Flinders rat model of depression.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 404-412.
https://doi.org/10.1016/j.euroneuro.2014.12.003
Berardelli, A., Wenning, G. K., Antonini, A., Berg, D., Bloem, B. R., Bonifati, V.
, Brooks, D., Burn, D. J., Colosimo, C., Fanciulli, A., Ferreira, J., Gasser, T., Grandas, F., Kanovsky, P., Kostic, V., Kulisevsky, J., Oertel, W., Poewe, W., Reese, J. P. ... Vidailhet, M. (2013).
EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease.
European Journal of Neurology,
20(1), 16-34.
https://doi.org/10.1111/ene.12022
Landau, A. M., Doudet, D.
, Alstrup, A. K. O., Jakobsen, S., Gjedde, A. & Dyve, S. (2011).
Effects of vagal nerve stimulation on noradrenaline receptor binding in minipigs by positron emission tomography. Abstract from Danish Epilepsy Meeting, Vejle, Denmark.
Egefjord, L.
, Jensen, M. G., Møller, A., Brændgaard, H., Gottrup, H., Antropova, O.
, Møller, N., Poulsen, H.
, Gjedde, A., Brock, B.
& Rungby, J. (2012).
Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial.
Danish Medical Journal,
59(10), A4519.
http://www.danmedj.dk/portal/page/portal/danmedj.dk/dmj_forside/PAST_ISSUE/2012/DMJ_2012_10/A4519
Gejl, M., Gjedde, A., Brock, B.
, Møller, A., van Duinkerken, E., Haahr, H. L., Hansen, C. T., Chu, P.-L., Stender-Petersen, K. L.
& Rungby, J. (2018).
Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial.
Diabetologia,
61(3), 551-561.
https://doi.org/10.1007/s00125-017-4502-1
Alstrup, A. K. O., Landau, A. M., Holden, J. E.
, Jakobsen, S., Schacht, A. C. S.
, Audrain, H., Wegener, G., Hansen, A. K., Gjedde, A. & Doudet, D. (2013).
Effects of anesthesia and species on the uptake or binding of radioligands in vivo in the Göttingen minipig.
BioMed Research International,
2013(808713), 1-9.
Lam, H. R., Larsen, J.-J., Ladefoged, O.
, Møller, A., Strange, P. & Arlien-Søborg, P. (1990).
Effects of 2,5-Hexanedione alone and in combination with acetone on radial arm maze behavior, the "Brain-Swelling" reaction and synaptosomal functions.
Neurotoxicology and Teratology,
13, 401-6.
Pilegaard, A. M., Berendt, M., Holst, P.
, Møller, A. & McEvoy, F. J. (2017).
Effect of Skull Type on the Relative Size of Cerebral Cortex and Lateral Ventricles in Dogs.
Frontiers in Veterinary Science,
4(MAR), 30. Article 30.
https://doi.org/10.3389/fvets.2017.00030
Pitkänen, A., Mathiesen, C., Rønn, L. C. B.
, Møller, A. & Nissinen, J. (2007).
Effect of novel AMPA antagonist, NS 1209, on status epilepticus, an experimental study in rat.
Epilepsy Research, (3780), 1-10.
Phan, J.-A., Stokholm, K., Zareba-Paslawska, J.
, Jakobsen, S., Vang, K., Gjedde, A.
, Landau, A. M. & Romero-Ramos, M. (2017).
Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
Scientific Reports,
7(1), Article 6363.
https://doi.org/10.1038/s41598-017-06724-9
Morbelli, S., Esposito, G., Arbizu, J., Barthel, H., Boellaard, R., Bohnen, N.
, Brooks, D. J., Darcourt, J., Dickson, J. C., Douglas, D., Drzezga, A., Dubroff, J., Ekmekcioglu, O., Garibotto, V., Herscovitch, P., Kuo, P., Lammertsma, A., Pappata, S., Penuelas, I. ... Law, I. (2020).
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0.
European Journal of Nuclear Medicine and Molecular Imaging,
47(8), 1885-1912.
https://doi.org/10.1007/s00259-020-04817-8
Hagell, P., Piccini, P., Björklund, A., Brundin, P., Rehncrona, S., Widner, H., Crabb, L.
, Pavese, N., Oertel, W. H., Quinn, N.
, Brooks, D. J. & Lindvall, O. (2002).
Dyskinesias following neural transplantation in parkinson’s disease.
Nature Neuroscience,
5(7), 627-628.
https://doi.org/10.1038/nn863
Schubert, J. J., Veronese, M., Marchitelli, L., Bodini, B., Tonietto, M., Stankoff, B.
, Brooks, D. J., Bertoldo, A., Edison, P. & Turkheimer, F. E. (2019).
Dynamic
11C-PIB PET shows cerebrospinal fluid flow alterations in Alzheimer disease and multiple sclerosis.
Journal of Nuclear Medicine,
60(10), 1452-1460.
https://doi.org/10.2967/jnumed.118.223834
Palermo, G., Giannoni, S., Frosini, D., Morganti, R., Volterrani, D., Bonuccelli, U.
, Pavese, N. & Ceravolo, R. (2020).
Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single-Photon Emission Computed Tomography Study.
Movement Disorders,
35(6), 1028-1036.
https://doi.org/10.1002/mds.28008
Piccini, P., Morrish, P. K., Turjanski, N., Sawle, G. V., Burn, D. J., Weeks, R. A., Mark, M. H., Maraganore, D. M., Lees, A. J.
& Brooks, D. J. (1997).
Dopaminergic function in familial Parkinson's disease: A clinical and 18F-dopa positron emission tomography study.
Annals of Neurology,
41(2), 222-229.
https://doi.org/10.1002/ana.410410213
Khan, N. L., Scherfler, C., Graham, E., Bhatia, K. P., Quinn, N., Lees, A. J.
, Brooks, D. J., Wood, N. W. & Piccini, P. (2005).
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.
Neurology,
64(1), 134-136.
https://doi.org/10.1212/01.WNL.0000148725.48740.6D
Callesen, M. B., Hansen, K. V.
, Gjedde, A., Linnet, J.
& Møller, A. (2013).
Dopaminergic and clinical correlates of pathological gambling in Parkinson's disease: A case report.
Frontiers in Behavioral Neuroscience,
7(95), 1-8.
https://doi.org/10.3389/fnbeh.2013.00095
Linnet, J.
, Møller, A., Peterson, E.
, Gjedde, A. & Doudet, D. (2011).
Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling. Addiction,
106(2), 383-390.
Piccini, P.
, Brooks, D. J., Björklund, A., Gunn, R. N., Grasby, P. M., Rimoldi, O., Brundin, P., Hagell, P., Rehncrona, S., Widner, H. & Lindvall, O. (1999).
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
Nature Neuroscience,
2(12), 1137-1140.
https://doi.org/10.1038/16060
Goerendt, I. K., Messa, C., Lawrence, A. D., Grasby, P. M., Piccini, P.
& Brooks, D. J. (2003).
Dopamine release during sequential finger movements in health and Parkinson's disease: A PET study.
Brain,
126(2), 312-325.
https://doi.org/10.1093/brain/awg035
Peterson, E.
, Gjedde, A., Rodell, A., Cumming, P.
, Møller, A. & Linnet, J. (2006).
Dopamine receptor availability linked to dopamine occupancy during gambling. Poster session presented at 6th Neuroreceptor Mapping Symposium, Copenhagen, Denmark.
Linnet, J., Peterson, E., Doudet, D.
, Gjedde, A. & Møller, A. (2009).
Dopamine is associated with maladaptive gambling in pathological gamblers.. Poster session presented at Society for Neuroscience, Chicago, United States.
Khodaii, J., Nomura, Y., Chang, N. H. S., Wong, D. F.
, Møller, A. & Gjedde, A. (2023).
Dopamine D2/3 Receptor Availabilities in Striatal and Extrastriatal Regions of the Adult Human Brain: Comparison of Four Methods of Analysis.
Neurochemical Research,
48(5), 1517-1530.
https://doi.org/10.1007/s11064-022-03825-4
Femminella, G. D., Ninan, S., Atkinson, R., Fan, Z.
, Brooks, D. J. & Edison, P. (2016).
Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia? Journal of Alzheimer's Disease,
51(4), 1275-1289.
https://doi.org/10.3233/JAD-150827
Femminella, G. D., Livingston, N. R., Raza, S., van der Doef, T., Frangou, E., Love, S., Busza, G., Calsolaro, V., Carver, S., Holmes, C., Ritchie, C. W., Lawrence, R. M., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E. ... Edison, P. (2021).
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects? Alzheimer's Research & Therapy,
13(1), Article 47.
https://doi.org/10.1186/s13195-021-00784-w
Parbo, P., Ismail, R., Sommerauer, M.
, Stokholm, M. G., Hansen, A. K., Hansen, K. V., Amidi, A., Schaldemose, J. L., Gottrup, H., Brændgaard, H.
, Eskildsen, S. F., Borghammer, P., Hinz, R.
, Aanerud, J. & Brooks, D. J. (2018).
Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study.
Neurobiology of Disease,
117, 211-216.
https://doi.org/10.1016/j.nbd.2018.06.004
Lippa, C. F., Duda, J. E., Grossman, M., Hurtig, H. I., Aarsland, D., Boeve, B. F.
, Brooks, D. J., Dickson, D. W., Dubois, B., Emre, M., Fahn, S., Farmer, J. M., Galasko, D., Galvin, J. E., Goetz, C. G., Growdon, J. H., Gwinn-Hardy, K. A., Hardy, J., Heutink, P. ... Wszolek, Z. K. (2007).
DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers.
Neurology,
68(11), 812-819.
https://doi.org/10.1212/01.wnl.0000256715.13907.d3
Goerendt, I. K., Lawrence, A. D., Mehta, M. A., Stern, J. S., Odin, P.
& Brooks, D. J. (2006).
Distributed neural actions of anti-parkinsonian therapies as revealed by PET.
Journal of Neural Transmission,
113(1), 75-86.
https://doi.org/10.1007/s00702-005-0305-5
Turner, M. R., Hammers, A., Al-Chalabi, A., Shaw, C. E.
, Andersen, P. M., Brooks, D. J. & Leigh, P. N. (2005).
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: Studies with [11C]flumazenil PET.
Brain,
128(6), 1323-1329.
https://doi.org/10.1093/brain/awh509
Nielsen, R. B., Egefjord, L.
, Eskildsen, S. F., Møller, A., Brændgaard, H.
, Jensen, M. G., Brock, B.
, Rungby, J. & Østergaard, L. (2016).
Disruption of microvascular flow-patterns in Alzheimer's disease correlates with neurodegeneration and cognitive decline. Abstract from 10th FENS Forum of Neuroscience 2016.
Fernandes, H. M., Cabral, J., van Hartevelt, T. J., Lord, L. D., Gleesborg, C.
, Møller, A., Deco, G., Whybrow, P. C., Petrovic, P., James, A. C.
& Kringelbach, M. L. (2019).
Disrupted brain structural connectivity in Pediatric Bipolar Disorder with psychosis.
Scientific Reports,
9(1), Article 13638.
https://doi.org/10.1038/s41598-019-50093-4
Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M.
, Brooks, D. J., Svendsen, C. N. & Heywood, P. (2003).
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.
Nature Medicine,
9(5), 589-595.
https://doi.org/10.1038/nm850
Kobylecki, C., Counsell, S. J., Cabanel, N., Wächter, T., Turkheimer, F. E., Eggert, K., Oertel, W.
, Brooks, D. J. & Gerhard, A. (2013).
Diffusion-weighted imaging and its relationship to microglial activation in parkinsonian syndromes.
Parkinsonism & Related Disorders,
19(5), 527-32.
https://doi.org/10.1016/j.parkreldis.2013.01.017
Pasquini, J., Firbank, M. J., Ceravolo, R., Silani, V.
& Pavese, N. (2022).
Diffusion Magnetic Resonance Imaging Microstructural Abnormalities in Multiple System Atrophy: A Comprehensive Review.
Movement Disorders,
37(10), 1963-1984.
https://doi.org/10.1002/mds.29195
Fearnley, J. M., Revesz, T.
, Brooks, D. J., Frackowiak, R. S. J. & Lees, A. J. (1991).
Diffuse Lewy body disease presenting with a supranuclear gaze palsy.
Journal of Neurology Neurosurgery and Psychiatry,
54(2), 159-161.
https://doi.org/10.1136/jnnp.54.2.159
Galgani, A., Palermo, G., Lombardo, F., Martini, N., Bastiani, L., Vergallo, A., Tommasini, L., Bellini, G., Baldacci, F., Frosini, D., Tognoni, G., Gesi, M., Cademartiri, F., Fornai, F.
, Pavese, N., Ceravolo, R. & Giorgi, F. S. (2023).
Different Patterns of Locus Coeruleus MRI Alteration in Alzheimer’s and Dementia with Lewy Bodies.
Current Alzheimer research,
20(4), 277-288.
https://doi.org/10.2174/1567205020666230721144603
Jabbari, E., Holland, N., Chelban, V., Jones, P. S., Lamb, R., Rawlinson, C., Guo, T., Costantini, A. A., Tan, M. M. X., Heslegrave, A. J., Roncaroli, F., Klein, J. C., Ansorge, O., Allinson, K. S. J., Jaunmuktane, Z., Holton, J. L., Revesz, T., Warner, T. T., Lees, A. J. ... Morris, H. R. (2020).
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
JAMA Neurology,
77(3), 377-387.
https://doi.org/10.1001/jamaneurol.2019.4347
Al-Absi, A.-R., Thambiappa, S. K., Khan, A. R.
, Glerup, S., Sanchez, C., Landau, A. M. & Nyengaard, J. R. (2022).
Df(h22q11)/+ mouse model exhibits reduced binding levels of GABAA receptors and structural and functional dysregulation in the inhibitory and excitatory networks of hippocampus.
Molecular and Cellular Neuroscience,
122, Article 103769.
https://doi.org/10.1016/j.mcn.2022.103769
Sørensen, J. C. H., Nielsen, M. S., Rosendal, F., Deding, D., Ettrup, K. S. E., Jensen, K. N., Jørgensen, R. L.
, GLUD, AN., Meier, K., Moberg Fitting, L., Møller, A., Alstrup, A. K. O., Østergaard, L. & Bjarkam, C. R. (2011).
Development of neuromodulation treatments in a large animal model: Do neurosurgeons dream of electric pigs? Progress in Brain Research,
194, 97-103.
https://doi.org/10.1016/B978-0-444-53815-4.00014-5
Rascol, O.
, Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., Lang, A. E., Abdalla, M., Harmant, J., Jacquy, J., King, D., Martin, W., Destee, A., Durif, F., Aharon-Peretz, J., Reches, A., Bergamasco, B., Bracco, F., Frattolla, L., Nordera, P. ... Wroe, S. V. (2006).
Development of dyskinesias in a 5-year trial and ropinirole and L-dopa.
Movement Disorders,
21(11), 1844-1850.
https://doi.org/10.1002/mds.20988
Wenning, G. K., Tison, F., Seppi, K., Sampiao, C., Diem, A., Yekhlef, F., Ghorayeb, I., Ory, F., Galitzky, M., Scaravilli, T., Bozi, M., Colosimo, C., Gilman, S., Shults, C. W., Quinn, N. P., Rascol, O., Poewe, W., Dupont, E., Ostergaard, K. ... Bergquist, J. (2004).
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).
Movement Disorders,
19(12), 1391-1402.
https://doi.org/10.1002/mds.20255
Sigurdsson, H. P., Alcock, L., Firbank, M., Wilson, R., Brown, P., Maxwell, R., Bennett, E.
, Pavese, N., Brooks, D. J. & Rochester, L. (2024).
Developing a novel dual-injection FDG-PET imaging methodology to study the functional neuroanatomy of gait.
NeuroImage,
288, Article 120531.
https://doi.org/10.1016/j.neuroimage.2024.120531
Politis, M., Wu, K., Loane, C., Turkheimer, F. E., Molloy, S.
, Brooks, D. J. & Piccini, P. (2010).
Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures.
Neurology,
75(21), 1920-1927.
https://doi.org/10.1212/WNL.0b013e3181feb2ab
Ring, H. A., Bench, C. J., Trimble, M. R.
, Brooks, D. J., Frackowiak, R. S. J. & Dolan, R. J. (1994).
Depression in Parkinson's disease. A positron emission study.
British Journal of Psychiatry,
165(SEP.), 333-339.
Remy, P., Doder, M., Lees, A., Turjanski, N.
& Brooks, D. (2005).
Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system.
Brain,
128(6), 1314-1322.
https://doi.org/10.1093/brain/awh445
Møller, A., Callesen, M. B., Thomsen, K. R.
, Gjedde, A. & Linnet, J. (2006).
Den spilreducerende spilleautomat. Poster session presented at Forskningens Dag, Århus, Denmark.
Fast, R., Rodell, A.
, Alstrup, A. K. O., Berendt, M.
& Møller, A. (2011).
Dementia in geriatric canines. Abstract from Tenth OAK Annual Meeting, Aarhus C, Denmark.
Piccini, P., Lindvall, O., Björklund, A., Brundin, P., Hagell, P., Ceravolo, R., Oertel, W., Quinn, N., Samuel, M., Rehncrona, S., Widner, H.
& Brooks, D. J. (2000).
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts.
Annals of Neurology,
48(5), 689-695.
https://doi.org/10.1002/1531-8249(200011)48:5<689::AID-ANA1>3.0.CO;2-N
Landau, A., Luk, K. C., Jones, M.-L., Siegrist-Johnstone, R., Young, Y. K., Kouassi, E., Rymar, V. V., Dagher, A., Sadikot, A. F. & Desbarats, J. (2005).
Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's disease.
Journal of Experimental Medicine,
202(5), 575-81.
https://doi.org/10.1084/jem.20050163
Sommerauer, M.
, Hansen, A. K., Parbo, P., Fedorova, T. D., Knudsen, K., Frederiksen, Y., Nahimi, A., Barbe, M. T.
, Brooks, D. J. & Borghammer, P. (2018).
Decreased noradrenaline transporter density in the motor cortex of Parkinson's disease patients.
Movement Disorders,
33(6), 1006-1010.
https://doi.org/10.1002/mds.27411
Landau, A. M., Phan, J.-A., Iversen, P., Lillethorup, T. P., Simonsen, M.
, Wegener, G., Jakobsen, S. & Doudet, D. J. (2015).
Decreased in vivo α2 adrenoceptor binding in the Flinders Sensitive Line rat model of depression.
Neuropharmacology,
91, 97-102.
https://doi.org/10.1016/j.neuropharm.2014.12.025
Fedorova, T. D., Seidelin, L. B.
, Knudsen, K., Schacht, A. C., Geday, J.
, Pavese, N., Brooks, D. J. & Borghammer, P. (2017).
Decreased intestinal acetylcholinesterase in early Parkinson disease; An 11C-donepezil PET study.
Neurology,
88(8).
https://doi.org/10.1212/WNL.0000000000003633
Paoli, D., Mills, R., Brechany, U.
, Pavese, N. & Nicholson, C. (2023).
DBS in tremor with dystonia: VIM, GPi or both? A review of the literature and considerations from a single-center experience.
Journal of Neurology,
270(4), 2217-2229.
https://doi.org/10.1007/s00415-023-11569-6
Turner, M. R., Hammers, A., Al-Chalabi, A., Shaw, C. E.
, Andersen, P. M., Brooks, D. J. & Leigh, P. N. (2007).
Cortical involvement in four cases of primary lateral sclerosis using [11C]-flumazenil PET. In
Cortical involvement in four cases of primary lateral sclerosis using [11C]-flumazenil PET (8 ed., Vol. 254, pp. 1033-1036)
https://doi.org/10.1007/s00415-006-0482-7
Richardson, M. P., Fristen, K. J., Sisodiya, S. M., Koepp, M. J., Ashburner, J., Free, S. L.
, Brooks, D. J. & Duncan, J. S. (1997).
Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data.
Brain,
120(11), 1961-1973.
https://doi.org/10.1093/brain/120.11.1961
Kew, J. J. M.
, Brooks, D. J., Rassingham, R. E., Rothwell, J. C., Frackowiak, R. S. J. & Leigh, P. N. (1994).
Cortical function in progressive muscular atrophy and amyotrophic lateral sclerosis.
Journal of the Neurological Sciences,
124(SUPPL.).
https://doi.org/10.1016/0022-510X(94)90184-8
Kew, J. J. M., Leigh, P. N., Playford, E. D., Passingham, R. E., Goldstein, L. H., Frackowiak, R. S. J.
& Brooks, D. J. (1993).
Cortical function in amyotrophic lateral sclerosis: A positron emission tomography study.
Brain,
116(3), 655-680.
https://doi.org/10.1093/brain/116.3.655
Hu, M. T. M., Taylor-Robinson, S. D., Chaudhuri, K. R., Bell, J. D., Labbé, C., Cunningham, V. J., Koepp, M. J., Hammers, A., Morris, R. G., Turjanski, N.
& Brooks, D. J. (2000).
Cortical dysfunction in non-demented Parkinson's disease patients. A combined 31P-MRS and 18FDG-PET study.
Brain,
123(2), 340-352.
https://doi.org/10.1093/brain/123.2.340
Pavese, N., Politis, M., Tai, Y. F., Barker, R. A., Tabrizi, S. J., Mason, S. L.
, Brooks, D. J. & Piccini, P. (2010).
Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers.
Neurobiology of Disease,
37(2), 356-361.
https://doi.org/10.1016/j.nbd.2009.10.015
Anderson, T. J., Jenkins, I. H.
, Brooks, D. J., Hawken, M. B., Frackowiak, R. S. J. & Kennard, C. (1994).
Cortical control of saccades and fixation in man A PET study.
Brain,
117(5), 1073-1084.
https://doi.org/10.1093/brain/117.5.1073
Weeks, R. A., Ceballos-Baumann, A., Piccini, P., Boecker, H., Harding, A. E.
& Brooks, D. J. (1997).
Cortical control of movement in Huntington's disease. A PET activation study.
Brain,
120(9), 1569-1578.
https://doi.org/10.1093/brain/120.9.1569
Stær, K., Iranzo, A.
, Stokholm, M. G., Østergaard, K., Serradell, M.
, Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Santamaria, J., Møller, A., Gaig, C.
, Brooks, D. J., Borghammer, P., Tolosa, E.
& Pavese, N. (2020).
Cortical cholinergic dysfunction correlates with microglial activation in the substantia innominata in REM sleep behavior disorder.
Parkinsonism & Related Disorders,
81, 89-93.
https://doi.org/10.1016/j.parkreldis.2020.10.014
Staer, K., Iranzo, A.
, Stokholm, M., Stergaard, Eroles, M.
, Otto, M., Svendsen, K., Pla, A., Vilas, D., Santamaria, J.
, Moller, A., Gaig, C.
, Borghammer, P., Brooks, D., Tolosa, E.
& Pavese, N. (2019).
Cortical cholinergic dysfunction correlates with microglial activation in the Substantia Innominata in patients with REM sleep behavior disorder. S830-S830. Abstract from International Congress of Parkinson's Disease and Movement Disorders, Nice, France.
Hvilsom, A. S. T.
, Lillethorup, T. P., Iversen, P., Doudet, D. J.
, Wegener, G. & Landau, A. M. (2019).
Cortical and striatal serotonin transporter binding in a genetic rat model of depression and in response to electroconvulsive stimuli.
European Neuropsychopharmacology,
29(4), 493-500.
https://doi.org/10.1016/j.euroneuro.2019.02.009
Turner, M. R., Rabiner, E. A., Al-Chalabi, A., Shaw, C. E.
, Brooks, D. J., Leigh, P. N.
& Andersen, P. M. (2007).
Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS.
Neurology,
68(15), 1233-1235.
https://doi.org/10.1212/01.wnl.0000259083.31837.64
Hu, M. T. M., White, S. J., Chaudhuri, K. R., Morris, R. G., Bydder, G. M.
& Brooks, D. J. (2001).
Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline.
Journal of Neural Transmission,
108(5), 571-580.
https://doi.org/10.1007/s007020170057
Klinge, P. M.
, Brooks, D. J., Samii, A., Weckesser, E., van den Hoff, J., Fricke, H., Brinker, T., Knapp, W. H. & Berding, G. (2008).
Correlates of local cerebral blood flow (CBF) in normal pressure hydrocephalus patients before and after shunting-A retrospective analysis of [15O]H2O PET-CBF studies in 65 patients.
Clinical Neurology and Neurosurgery,
110(4), 369-375.
https://doi.org/10.1016/j.clineuro.2007.12.019
Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B. R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K. ... Edison, P. (2020).
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Trials,
21, Article 660.
https://doi.org/10.1186/s13063-020-04608-4
Okello, A., Koivunen, J., Edison, P., Archer, H. A., Turkheimer, F. E., Någren, K., Bullock, R., Walker, Z., Kennedy, A., Fox, N. C., Rossor, M. N., Rinne, J. O.
& Brooks, D. J. (2009).
Conversion of amyloid positive and negative mci to ad over 3 years: An c-pib pet study symbol.
Neurology,
73(10), 754-760.
https://doi.org/10.1212/WNL.0b013e3181b23564
Rogers, R. D., Andrews, T. C., Grasby, P. M.
, Brooks, D. J. & Robbins, T. W. (2000).
Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans.
Journal of Cognitive Neuroscience,
12(1), 142-162.
https://doi.org/10.1162/089892900561931
Deuschl, G., Bain, P., Brin, M., Agid, Y., Benabid, L., Benecke, R., Berardelli, A.
, Brooks, D. J., Elble, R., Fahn, S., Findley, L. J., Hallett, M., Jankovic, J., Koller, W. C., Krack, P., Lang, A. E., Lees, A., Lucking, C. H., Marsden, C. D. ... Toloso, E. (1998).
Consensus statement of the Movement Disorder Society on tremor.
Movement Disorders,
13(SUPPL. 3), 2-23.
Sridharan, S., Raffel, J., Nandoskar, A., Record, C.
, Brooks, D., Owen, D., Sharp, D., Muraro, P., Gunn, R. & Nicholas, R. (2019).
Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [
18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter.
Multiple Sclerosis Journal,
21(5), 935-944.
https://doi.org/10.1007/s11307-019-01323-8
Evans, A. H.
, Pavese, N., Lawrence, A. D., Tai, Y. F., Appel, S., Doder, M.
, Brooks, D. J., Lees, A. J. & Piccini, P. (2006).
Compulsive drug use linked to sensitized ventral striatal dopamine transmission.
Annals of Neurology,
59(5), 852-858.
https://doi.org/10.1002/ana.20822
Edison, P., Carter, S. F., Rinne, J. O., Gelosa, G., Herholz, K., Nordberg, A.
, Brooks, D. J. & Hinz, R. (2013).
Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET.
NeuroImage,
70, 423-33.
https://doi.org/10.1016/j.neuroimage.2012.12.014
Lammertsma, A. A., Bench, C. J., Hume, S. P., Osman, S., Gunn, K.
, Brooks, D. J. & Frackowiak, R. S. J. (1996).
Comparison of Methods for Analysis of Clinical [1C]Raclopride Studies.
Journal of Cerebral Blood Flow and Metabolism,
16(1), 42-52.
https://doi.org/10.1097/00004647-199601000-00005
Peterson, E.
, Gjedde, A., Møller, A., Linnet, J., Doudet, D. & Rodell, A. (2008).
Comparison of four methods of measurement on [11C]Raclopride binding potential using regional specificity in the striatum. Poster session presented at Dopamine 50 Years, Sweden.
Koepp, M. J., Hansen, M. L., Pressler, R. M.
, Brooks, D. J., Brandl, U., Guldin, B., Duncan, J. S. & Ried, S. (1998).
Comparison of EEG, MRI and PET in reading epilepsy: A case report.
Epilepsy Research,
29(3), 251-257.
McGinnity, C. J., Årstad, E., Beck, K.
, Brooks, D. J., Coles, J. P., Duncan, J. S., Galovic, M., Hinz, R., Hirani, E., Howes, O. D., Jones, P. A., Koepp, M. J., Luo, F., Riaño Barros, D. A., Singh, N., Trigg, W. & Hammers, A. (2019).
Comment on " In Vivo [18F]GE-179 Brain Signal Does Not Show NMDA-Specific Modulation with Drug Challenges in Rodents and Nonhuman Primates".
ACS Chemical Neuroscience,
10(1), 768-772.
https://doi.org/10.1021/acschemneuro.8b00246
Landau, A. M., Alstrup, A. K. O., Wegener, G., Jakobsen, S., Schacht, A. C., Jacobsen, J., Mørk, A.
, Sørensen, J. C. H. & Doudet, D. (2013).
Combined PET/microdialysis studies in minipig for PET tracer validation. Abstract from Minipig Research Forum, Rom, Italy.
Khan, S., Gill, S. S., Mooney, L., White, P., Whone, A.
, Brooks, D. J. & Pavese, N. (2012).
Combined pedunculopontine-subthalamic stimulation in Parkinson disease.
Neurology,
78(14), 1090-5.
https://doi.org/10.1212/WNL.0b013e31824e8e96
Landau, A., Jakobsen, S., Thomsen, M., Alstrup, A. K. O., Orlowski, D., Jacobsen, J., Wegener, G., Mørk, A.
, Sørensen, J. C. H. & Doudet, D. J. (2023).
Combined In Vivo Microdialysis and PET Studies to Validate [11C]Yohimbine Binding as a Marker of Noradrenaline Release.
Biomolecules,
13(4), Article 674.
https://doi.org/10.3390/biom13040674
Borghammer, P., Knudsen, K., Østergaard, K.
, Danielsen, E. H., Pavese, N., Arveschoug, A.
, Bluhme, H., Bode, M.
& Morsing, A. (2014).
Combined DaT imaging and olfactory testing for differentiating parkinsonian disorders.
International Journal of Clinical Practice,
68(11), 1345-51.
https://doi.org/10.1111/ijcp.12445